Cara Therapeutics reported $47K in Ordinary Share Capital for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Antares Pharma ATRS:US $ 1M 0M
Chugai Pharma 4519:JP Y 73202M 0M
Depomed DEPO:US $ 0.01M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Horizon Pharma HZNP:US $ 0.02M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Pfizer PFE:US $ 470M 0M
Redhill Biopharma RDHL:US $ 1.02M 0.04M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M